Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase I Study of the Immune Response to Herpes Simplex Virus Type 1 (HSV-1) and General Immune Health in Subjects Infected With HSV-1

Trial Profile

A Phase I Study of the Immune Response to Herpes Simplex Virus Type 1 (HSV-1) and General Immune Health in Subjects Infected With HSV-1

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Feb 2019

At a glance

  • Drugs Squaric acid dibutylester (Primary)
  • Indications Herpes simplex virus type 1 infections
  • Focus Pharmacodynamics; Pharmacogenomic
  • Sponsors Squarex
  • Most Recent Events

    • 14 Feb 2019 According to a Squarex media release, clinical data from the study has been published in the peer-reviewed journal Immunity, Inflammation and Disease.
    • 14 Feb 2019 Results presented in a Squarex media release.
    • 17 Sep 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top